IMO - Getting massive amounts of FUD over on Investorshub.

New Post Public Reply Private Reply Replies (0) Message Board
Pafiddler
648
IMO - Getting massive amounts of FUD over on Investorshub. I've got a boatload on ignore, so fortunately I don't have to waste time/life reading it all.

I did respond to some of the "stuff" but four of my posts were removed (smile) so I thought I'd have a bit of fun here.

I thought I'd share those posts here instead...

You, at least, might get a chuckle out of it.

Go Leronlimab!!!!

******

Being here is like watching the local "Halloween Parade"

Lots of scary characters mumbling negative Cytodyn, Nader, Proactive, and assorted stuff.

Great costumes but the reality is
Leronlimab is good stuff
It works
It's relatively harmless

And the "weeners" want your shares for cheap...but then
So do I

Hang tight and enjoy the "strange parade."
Some very creative FUDDING afoot...oh look at that one playing the "fife."

Very entertaining...

GO leronlimab!
***

This board, while it shares some great information on CytoDyn and Leronlimab, seems to have an infestation (IMO) of those seeking to impede leronlimab on its journey to SAVE. Of course this is a good place for them. They can carry on about financing, make fun of the company's leadership, "dis" the testing results, try to suggest this company is a sham, repeat the same time-worn false assertions, harrass Leronlimab's supporters and, for the newbie stopping by, make Cytodyn appear to be some kind of sloppy jallopy driven by a bunch of crazy crooks and their supporters a bumbling bunch.

Thank you.

I appreciate your many "handles" and your blatant attempts to staunch the flow of support for CytoDyn. Your names, comments, and blatant position(s) are naked to onlookers and/or investigators, and further, are entrenched in the records to be read at will.

I, and many others, am here to learn more about the CytoDyn and its drug Leronlimab. We support the use of leronlimab to save lives and make things better for families worldwide. I like Leronlimab so much that I have invested significant time and (for me) money in this company and want to see it succeed in making this drug available. I would be proud if the drug I supported started to save the lives of those living with CANCER, struggling after strokes, trying to get by with HIV, watching as neurodegeneration slowly steals one's reality, etc.

It's hard to imagine some relishing the result of NOT MAKING LERONLIMAB AVAILABLE. I MEAN - it sincerely appears some DON'T want Leronlimab to be in the hands of capable doctors. I don't see it a "win" when more people die, suffer, slowly watch their faculties fade, cancer spread throughout their body, etc. I've encountered those appearing to impede Leronlimab and its mission with badgering 24-7, but wonder wherein is the thrill?

I salute your efforts and will do my best to bring you the deserved notoriety, so your efforts will be heralded in the proper surroundings. I will further continue unabated to push for the approval of leronlimab/Vyroloix/Pro 140 to save lives and make the world a little bit better.
***
NOC WTF YT …OK? NP has to stop pissing off FDA.

Had a little trouble with the acronyms, but finally figured it out. Not much to do with leronlimab though.

No one can water the flowers your turn .....OK ? Not Pretty has to stop pissing off front driveway apron.

OH WELL

Leronlimab is effective
Leronlimab is safe
leronlimab is getting recognition and increasing respect.

LIE LIS LIGRAIR!

LOL
***
Casting aspersions. (I think I'd rather be fly fishing - casting the weight of the line not the bait)

Your reference to CROOKS, fine take it to the respective authorities and see if they are willing to prosecute, based on your facts and hard data. This is a board for discussion of CytoDyn and Leronlimab/Vyrologix/Pro140, not "New Detective" magazine.

LERONLIMAB = Great Drug
And it has a great future, and (like it or not) it wouldn't be possible but for Dr. Nader Pourhassan. His efforts could easily save your life or livelihood as well as mine! Some of the things Leronlimab can "tackle" give me hope as I look at my potential future afflictions! (Gastronomical observation: I SUSPECT crow tastes sort of like chicken.)

Wouldn't it be CRAZY if Nader gets a NOBEL Prize? Whoa!!!

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 210

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 460

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 213

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 215

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 423

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 285

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 245

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 256

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 334

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 272

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Primech AI Partners for HYTRON LITE Robot Deployment in Healthcare

Updated Category News Views 301

Primech AI Signs Lease Agreement for Innovative Robot Deployment Primech AI Pte. Ltd. ("Primech AI"), a proud subsidiary of Primech Holdings Limited (NASDAQ: PMEC), is thrilled to announce a pivotal lease agreement. This collaboration is with a leading provider in facility management to deploy the revolutionary HYTRON LITE autonomous bathroom cleaning robot at a prominent...

Continue Reading
Advancements in GABAB Program: Addex and Indivior Partnership

Updated Category News Views 274

Exciting Developments in GABAB Positive Allosteric Modulators Addex Therapeutics (SIX/NASDAQ: ADXN), a leader in developing innovative small molecule allosteric modulators for neurological disorders, has announced a significant advancement with its partner Indivior. Together, they have successfully moved the GABAB positive allosteric modulator (PAM) program through the...

Continue Reading
Diligent Unveils Innovative AI Toolkits for EU Compliance

Updated Category News Views 223

Diligent Unveils AI Toolkits to Help Meet EU AI Regulations LONDON--Diligent, a key player in governance, risk, and compliance software (GRC SaaS), has rolled out its new Artificial Intelligence (AI) Act Toolkits. These valuable resources are tailored for corporate secretaries, compliance teams, chief technology officers, and audit teams, helping them navigate the complex...

Continue Reading
Examining Oracle's Competitive Standings in Software Industry

Updated Category News Views 206

Understanding Oracle's Competitive Landscape In today's dynamic and competitive market, it's crucial for investors and enthusiasts to conduct a thorough analysis of companies. This article will explore a detailed comparison, particularly focusing on Oracle (NYSE: ORCL) and its major peers in the software sector. By reviewing various financial metrics, market positioning,...

Continue Reading
Enthusiast Gaming's Response to Postal Disruption for Meeting Materials

Updated Category News Views 122

Enthusiast Gaming Addresses Postal Strike Impact Enthusiast Gaming Holdings Inc. (TSX: EGLX) is a well-known digital publisher dedicated to creating enriching experiences for gamers. With the ongoing Canada Post strike creating potential disruptions, the Company is proactively addressing how it may affect shareholder communications, specifically regarding the meeting...

Continue Reading